Compare CMG & A Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CMG | A |
|---|---|---|
| Founded | 1993 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Restaurants | Biotechnology: Laboratory Analytical Instruments |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 42.6B | 38.0B |
| IPO Year | 2005 | 1999 |
| Metric | CMG | A |
|---|---|---|
| Price | $33.90 | $139.22 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 28 | 15 |
| Target Price | $46.85 | ★ $161.47 |
| AVG Volume (30 Days) | ★ 14.2M | 1.8M |
| Earning Date | 04-29-2026 | 05-27-2026 |
| Dividend Yield | N/A | ★ 0.92% |
| EPS Growth | 2.70 | ★ 3.16 |
| EPS | 0.55 | ★ 2.27 |
| Revenue | ★ $11,925,601,000.00 | $4,472,000,000.00 |
| Revenue This Year | $9.66 | $8.45 |
| Revenue Next Year | $11.03 | $6.13 |
| P/E Ratio | $68.13 | ★ $61.61 |
| Revenue Growth | 5.41 | ★ 6.43 |
| 52 Week Low | $28.10 | $108.35 |
| 52 Week High | $44.27 | $160.27 |
| Indicator | CMG | A |
|---|---|---|
| Relative Strength Index (RSI) | 62.74 | 58.34 |
| Support Level | $36.13 | $135.75 |
| Resistance Level | $37.47 | $139.38 |
| Average True Range (ATR) | 1.25 | 3.82 |
| MACD | 0.40 | 0.13 |
| Stochastic Oscillator | 78.02 | 80.05 |
Chipotle is a leading fast-casual, Mexican-inspired restaurant chain, generating $11.9 billion in sales across 3,983 company-operated US locations, 104 international units primarily in Canada and Europe, and 14 licensed stores largely operated in the Middle East at the end of 2025. The firm's revenue is primarily driven by food and beverage sales at its company-owned restaurants, supplemented by delivery fees generated through its first-party digital channels. Chipotle emphasizes ingredients with no artificial flavors and utilizes an efficient, assembly line service model to serve mainly customizable burritos, bowls, salads, quesadillas, and tacos.
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and diagnostics, cross lab operations consisting of consumables and services, and applied end markets. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest country concentrations.